Autolus Therapeutics (AUTL) Other financing activities (2022 - 2024)

Autolus Therapeutics' Other financing activities history spans 3 years, with the latest figure at $1.8 million for Q2 2024.

  • For Q2 2024, Other financing activities rose 740.18% year-over-year to $1.8 million; the TTM value through Mar 2025 reached $1.8 million, down 93.37%, while the annual FY2024 figure was $29.4 million, 3126.37% up from the prior year.
  • Other financing activities reached $1.8 million in Q2 2024 per AUTL's latest filing, down from $27.5 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $27.5 million in Q1 2024 to a low of $219000.0 in Q2 2023.
  • Average Other financing activities over 3 years is $8.1 million, with a median of $1.8 million recorded in 2024.
  • The largest YoY upside for Other financing activities was 3882.63% in 2024 against a maximum downside of 740.18% in 2024.
  • A 3-year view of Other financing activities shows it stood at $10.3 million in 2022, then crashed by 97.88% to $219000.0 in 2023, then surged by 740.18% to $1.8 million in 2024.
  • Per Business Quant, the three most recent readings for AUTL's Other financing activities are $1.8 million (Q2 2024), $27.5 million (Q1 2024), and $219000.0 (Q2 2023).